Immunotherapy

Catherine Poole breaks down the emerging immunotherapy options for Melanoma, not to be confused with the common skin cancers (basal-cell carcinoma and squamous-cell carcinoma) largely caused by exposure to UV rays. Read More ›

“We are continuing to learn about the ways the immune system interacts with difference types of cancer, including multiple myeloma,” said Dr. Pazdur of the FDA. Read More ›

Immunotherapy is all the rage today, but like any other treatment, it comes with side effects. Learn how to recognize and manage some of the common side effects. Read More ›

Immunotherapies expose cancer cells to the immune system so it can attack them. Read about why these drugs work so well in some patients but in others the immune system doesn’t respond to these very promising drugs. Read More ›

Check out some of the most exciting immunotherapies that are giving hope to people fighting this disease, which is responsible for 1 in every 4 cancer-related deaths in the United States. Read More ›

Take a look at the 5 new promising immunotherapies approved by the FDA for bladder cancer after decades of no new treatment options for this type of cancer. Read More ›

Read More ›

Read More ›

Lung cancer is the leading cause of cancer-related deaths in the United States. According to the American Cancer Society, approximately 224,390 people will be diagnosed with lung cancer in 2016, and more than 158,000 patients will die from this disease. Smoking is the major risk factor for lung cancer–80% of lung cancer deaths are related to smoking. Read More ›

“This therapy is an innovative approach, one that combines the precision of a targeted, immune-based therapy with traditional myeloma therapy. The results are very encouraging, giving renewed hope to patients who have relapsed,” says ASCO President-Elect Julie M. Vose, MD, MBA, Chief of the Division of Oncology/Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha. Read More ›